{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:30:56Z","timestamp":1792765856565,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T00:00:00Z","timestamp":1592611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T00:00:00Z","timestamp":1592611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00277-020-04144-w","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T11:02:58Z","timestamp":1592650978000},"page":"1925-1932","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["An eleven-year cohort of bloodstream infections in 552 febrile neutropenic patients: resistance profiles of Gram-negative bacteria as a predictor of mortality"],"prefix":"10.1007","volume":"99","author":[{"given":"Ritvan","family":"Kara Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7239-1133","authenticated-orcid":false,"given":"Serkan","family":"Surme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilker Inanc","family":"Balkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse","family":"Salihoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryem","family":"Sahin Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilgul","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunay","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhlis Cem","family":"Ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fehmi","family":"Tabak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nese","family":"Saltoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,20]]},"reference":[{"key":"4144_CR1","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR, Infectious Diseases Society of America (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:e56\u2013e93. https:\/\/doi.org\/10.1093\/cid\/cir073","journal-title":"Clin Infect Dis"},{"key":"4144_CR2","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3324\/haematol.2013.091025.DE","volume":"98","author":"D Averbuch","year":"2013","unstructured":"Averbuch D, Orasch C, Cordonnier C, Livermore DM, Mikulska M, Viscoli C, Gyssens IC, Kern WV, Klyasova G, Marchetti O, Engelhard D, Akova M, on behalf of ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH\/ESCMID and ELN (2013) European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance. Haematologica 98:1826\u20131835. https:\/\/doi.org\/10.3324\/haematol.2013.091025.DE","journal-title":"Haematologica"},{"issue":"14","key":"4144_CR3","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","volume":"36","author":"RA Taplitz","year":"2018","unstructured":"Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, Langston AA, Nastoupil LJ, Rajotte M, Rolston K, Strasfeld L, Flowers CR (2018) Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update. J Clin Oncol 36(14):1443\u20131453. https:\/\/doi.org\/10.1200\/JCO.2017.77.6211","journal-title":"J Clin Oncol"},{"key":"4144_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/QCO.0000000000000038","volume":"27","author":"EM Trecarichi","year":"2014","unstructured":"Trecarichi EM, Tumbarello M (2014) Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact. Curr Opin Infect Dis 27:200\u2013210. https:\/\/doi.org\/10.1097\/QCO.0000000000000038","journal-title":"Curr Opin Infect Dis"},{"key":"4144_CR5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00277-011-1373-2","volume":"91","author":"L Pagano","year":"2012","unstructured":"Pagano L, Caira M, Rossi G et al (2012) A prospective survey of febrile events in hematological malignancies. Ann Hematol 91:767\u2013774. https:\/\/doi.org\/10.1007\/s00277-011-1373-2","journal-title":"Ann Hematol"},{"key":"4144_CR6","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1086\/374339","volume":"36","author":"H Wisplinghoff","year":"2003","unstructured":"Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB (2003) Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 36:1103\u20131110. https:\/\/doi.org\/10.1086\/374339","journal-title":"Clin Infect Dis"},{"key":"4144_CR7","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1469-0691.2012.03879.x","volume":"19","author":"C Gudiol","year":"2013","unstructured":"Gudiol C, Bodro M, Simonetti A, Tubau F, Gonz\u00e1lez-Barca E, Cisnal M, Domingo-Domenech E, Jim\u00e9nez L, Carratal\u00e0 J (2013) Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect 19:474\u2013479. https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03879.x","journal-title":"Clin Microbiol Infect"},{"key":"4144_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jinf.2013.12.006","volume":"68","author":"M Mikulska","year":"2014","unstructured":"Mikulska M, Viscoli C, Orasch C, Livermore DM, Averbuch D, Cordonnier C, Akova M, Fourth European Conference on Infections in Leukemia Group (ECIL-4), a joint venture of EBMT, EORTC, ICHS, ELN and ESGICH\/ESCMID (2014) Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients. J Inf Secur 68:321\u2013331. https:\/\/doi.org\/10.1016\/j.jinf.2013.12.006","journal-title":"J Inf Secur"},{"key":"4144_CR9","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s10096-006-0173-4","volume":"25","author":"A Safdar","year":"2006","unstructured":"Safdar A, Rodriguez GH, Balakrishnan M, Tarrand JJ, Rolston KVI (2006) Changing trends in etiology of bacteremia in patients with cancer. Eur J Clin Microbiol Infect Dis 25:522\u2013526. https:\/\/doi.org\/10.1007\/s10096-006-0173-4","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4144_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/00001432-200208000-00004","volume":"15","author":"C Viscoli","year":"2002","unstructured":"Viscoli C, Castagnola E (2002) Treatment of febrile neutropenia: what is new? Curr Opin Infect Dis 15:377\u2013382. https:\/\/doi.org\/10.1097\/00001432-200208000-00004","journal-title":"Curr Opin Infect Dis"},{"key":"4144_CR11","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2147\/TCRM.S68450","volume":"10","author":"H Gedik","year":"2014","unstructured":"Gedik H, \u015eim\u015fek F, Kant\u00fcrk A et al (2014) Bloodstream infections in patients with hematological malignancies: which is more fatal \u2013 cancer or resistant pathogens? Ther Clin Risk Manag 10:743\u2013752. https:\/\/doi.org\/10.2147\/TCRM.S68450","journal-title":"Ther Clin Risk Manag"},{"key":"4144_CR12","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1007\/s00520-013-1816-5","volume":"21","author":"G Samonis","year":"2013","unstructured":"Samonis G, Vardakas KZ, Maraki S, Tansarli GS, Dimopoulou D, Kofteridis DP, Andrianaki AM, Falagas ME (2013) A prospective study of characteristics and outcomes of bacteremia in patients with solid organ or hematologic malignancies. Support Care Cancer 21:2521\u20132526. https:\/\/doi.org\/10.1007\/s00520-013-1816-5","journal-title":"Support Care Cancer"},{"key":"4144_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.4274\/tjh.2014.0378","volume":"33","author":"M Yemi\u015fen","year":"2016","unstructured":"Yemi\u015fen M, Balkan \u0130\u0130, Saliho\u011flu A, Eskazan AE, Mete B, Ar MC, \u00d6ng\u00f6ren \u015e, Ba\u015flar Z, \u00d6zaras R, Salto\u011flu N, Mert A, Ferhano\u011flu B, \u00d6zt\u00fcrk R, Tabak F, Soysal T (2016) Hematopoetik k\u00f6k h\u00fccre nakli alicilarinda kan akim enfeksiyonu ve diren\u00e7 epidemiyolojisindeki de\u011fi\u015fim. Turkish J Hematol 33:216\u2013222. https:\/\/doi.org\/10.4274\/tjh.2014.0378","journal-title":"Turkish J Hematol"},{"issue":"10","key":"4144_CR14","doi-asserted-by":"publisher","first-page":"e0224299","DOI":"10.1371\/journal.pone.0224299","volume":"14","author":"RL Parodi","year":"2019","unstructured":"Parodi RL, Lagrutta M, Tortolo M, Navall E, Rodr\u00edguez MS, Sasia GF, de Candia LF, Gruvman MA, Bottasso O, Greca AA (2019) A multicenter prospective study of 515 febrile neutropenia episodes in Argentina during a 5-year period. PLoS One 14(10):e0224299. https:\/\/doi.org\/10.1371\/journal.pone.0224299","journal-title":"PLoS One"},{"issue":"1","key":"4144_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jinf.2017.10.009","volume":"76","author":"M Mikulska","year":"2018","unstructured":"Mikulska M, Averbuch D, Tissot F, Cordonnier C, Akova M, Calandra T, Ceppi M, Bruzzi P, Viscoli C, Akova M, Aljurf M, Averbuch D, Barnes R, Blennow O, Bochud PY, Bouza E, Bretagne S, Br\u00fcggemann R, Calandra T, Carratala J, Cesaro S, Cordonnier C, Cornely O, Dalianis T, de la Camara R, Donnelly P, Drgona L, Duarte R, Einsele H, Engelhard D, Fox C, Girmenia C, Groll A, Heldal D, Larsen JH, Herbrecht R, Hirsch H, Johnson E, Klyasova G, Koskuenvo M, Lagrou K, Lewis RE, Ljungman P, Maertens J, Maschmeyer G, Mikulska M, Nucci M, Padoin C, Pagano L, Pagliuca A, Racil Z, Ribaud P, Rinaldo C, Puechal VR, Roilides E, Robin C, Rovira M, Rupp M, Sanchez S, Schellongowski P, Sedlacek P, Sinko J, Slavin M, Ferreira IS, Styczynski J, Tissot F, Viscoli C, Ward K, Witschi AT (2018) Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines. J Inf Secur 76(1):20\u201337. https:\/\/doi.org\/10.1016\/j.jinf.2017.10.009","journal-title":"J Inf Secur"},{"issue":"6","key":"4144_CR16","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1080\/23744235.2017.1420221","volume":"50","author":"R R\u00f6nkk\u00f6","year":"2018","unstructured":"R\u00f6nkk\u00f6 R, Juutilainen A, Koivula I, V\u00e4nsk\u00e4 M, Nousiainen T, Jantunen E, H\u00e4m\u00e4l\u00e4inen S (2018) Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients. Infect Dis (Lond) 50(6):436\u2013442. https:\/\/doi.org\/10.1080\/23744235.2017.1420221","journal-title":"Infect Dis (Lond)"},{"key":"4144_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.blre.2008.10.003","volume":"23","author":"LJ Worth","year":"2009","unstructured":"Worth LJ, Slavin MA (2009) Bloodstream infections in haematology: risks and new challenges for prevention. Blood Rev 23:113\u2013122. https:\/\/doi.org\/10.1016\/j.blre.2008.10.003","journal-title":"Blood Rev"},{"key":"4144_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10096-018-3190-1","volume":"37","author":"V Daitch","year":"2018","unstructured":"Daitch V, Akayzen Y, Abu-Ghanem Y, Eliakim-Raz N, Paul M, Leibovici L, Yahav D (2018) Secular trends in the appropriateness of empirical antibiotic treatment in patients with bacteremia: a comparison between three prospective cohorts. Eur J Clin Microbiol Infect Dis 37:455\u2013462. https:\/\/doi.org\/10.1007\/s10096-018-3190-1","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4144_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/bmt.2014.231","volume":"50","author":"C Girmenia","year":"2015","unstructured":"Girmenia C, Rossolini GM, Piciocchi A et al (2015) Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy. Bone Marrow Transplant 50:282\u2013288. https:\/\/doi.org\/10.1038\/bmt.2014.231","journal-title":"Bone Marrow Transplant"},{"key":"4144_CR20","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00277-012-1424-3","volume":"91","author":"C Cattaneo","year":"2012","unstructured":"Cattaneo C, Antoniazzi F, Casari S, Ravizzola G, Gelmi M, Pagani C, D\u2019Adda M, Morello E, Re A, Borlenghi E, Manca N, Rossi G (2012) P. aeruginosa bloodstream infections among hematological patients: an old or new question? Ann Hematol 91:1299\u20131304. https:\/\/doi.org\/10.1007\/s00277-012-1424-3","journal-title":"Ann Hematol"},{"key":"4144_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/00365548.2013.857042","volume":"46","author":"SB Kim","year":"2014","unstructured":"Kim SB, Min YH, Cheong JW, Kim JS, Kim SJ, Ku NS, Jeong SJ, Han SH, Choi JY, Song YG, Kim JM (2014) Incidence and risk factors for carbapenem-and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipients. Scand J Infect Dis 46:81\u201388. https:\/\/doi.org\/10.3109\/00365548.2013.857042","journal-title":"Scand J Infect Dis"},{"key":"4144_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbmt.2008.10.024","volume":"15","author":"M Mikulska","year":"2009","unstructured":"Mikulska M, Del Bono V, Raiola AM et al (2009) Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant 15:47\u201353. https:\/\/doi.org\/10.1016\/j.bbmt.2008.10.024","journal-title":"Biol Blood Marrow Transplant"},{"key":"4144_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1590\/S0100-879X2009000300010","volume":"42","author":"M Garnica","year":"2009","unstructured":"Garnica M, Maiolino A, Nucci M (2009) Factors associated with bacteremia due to multidrug-resistant Gram-negative bacilli in hematopoietic stem cell transplant recipients. Brazilian J Med Biol Res 42:289\u2013293. https:\/\/doi.org\/10.1590\/S0100-879X2009000300010","journal-title":"Brazilian J Med Biol Res"},{"key":"4144_CR24","doi-asserted-by":"publisher","unstructured":"Beyar-Katz O, Dickstein Y, Borok S, Vidal L, Leibovici L, Paul M, Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group (2017) Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer. Cochrane Database Syst Rev 2017. https:\/\/doi.org\/10.1002\/14651858.CD003914.pub4","DOI":"10.1002\/14651858.CD003914.pub4"},{"key":"4144_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1155\/2014\/702621","volume":"25","author":"RG Rosa","year":"2014","unstructured":"Rosa RG, Dos Santos RP, Goldani LZ (2014) Mortality related to coagulase-negative staphylococcal bacteremia in febrile neutropenia: a cohort study. Can J Infect Dis Med Microbiol 25:14\u201318. https:\/\/doi.org\/10.1155\/2014\/702621","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"4144_CR26","doi-asserted-by":"publisher","unstructured":"Han SB, Bae EY, Lee JW, Lee DG, Chung NG, Jeong DC, Cho B, Kang JH, Kim HK (2013) Clinical characteristics and antimicrobial susceptibilities of viridans streptococcal bacteremia during febrile neutropenia in patients with hematologic malignancies: a comparison between adults and children. BMC Infect Dis 13:. https:\/\/doi.org\/10.1186\/1471-2334-13-273","DOI":"10.1186\/1471-2334-13-273"},{"key":"4144_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jinf.2009.02.002","volume":"58","author":"EM Trecarichi","year":"2009","unstructured":"Trecarichi EM, Tumbarello M, Spanu T, Caira M, Fianchi L, Chiusolo P, Fadda G, Leone G, Cauda R, Pagano L (2009) Incidence and clinical impact of extended-spectrum-\u03b2-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J Inf Secur 58:299\u2013307. https:\/\/doi.org\/10.1016\/j.jinf.2009.02.002","journal-title":"J Inf Secur"},{"key":"4144_CR28","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/jac\/dkw459","volume":"72","author":"E Righi","year":"2017","unstructured":"Righi E, Peri AM, Harris PNA, Wailan AM, Liborio M, Lane SW, Paterson DL (2017) Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis. J Antimicrob Chemother 72:668\u2013677. https:\/\/doi.org\/10.1093\/jac\/dkw459","journal-title":"J Antimicrob Chemother"},{"key":"4144_CR29","doi-asserted-by":"publisher","unstructured":"Albiger B, Glasner C, Struelens M et al (2015) Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national. Euro Surveill 20. https:\/\/doi.org\/10.2807\/1560-7917.ES.2015.20.45.30062","DOI":"10.2807\/1560-7917.ES.2015.20.45.30062"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04144-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-020-04144-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04144-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T23:14:49Z","timestamp":1624144489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-020-04144-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,20]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["4144"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-04144-w","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,20]]},"assertion":[{"value":"19 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was waived, given the retrospective nature of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}